Publication | Closed Access
Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma
41
Citations
26
References
2020
Year
Systemic SclerodermaMedicineImmunologyAutoimmunityBiological TherapyBleomycin-induced SclerodermaDermatologyImmunosuppressionSclerodermaImmunotherapyJaks Inhibitor TofacitinibMouse Model
| Year | Citations | |
|---|---|---|
Page 1
Page 1